BioSpace News Archive

Business

Aridis Pharmaceuticals Announces Third Quarter 2019 Results

Aridis Pharmaceuticals, Inc. reported financial and corporate results for the third quarter ended September 30, 2019.

November 13, 2019
·
16 min read
Business

Gamida Cell Reports Third Quarter 2019 Financial Results and Provides Company Update

Additional results from Phase 1 study of GDA-201 and new data on NAM technology platform to be presented at 61st Annual Meeting of the American Society of Hematology

November 13, 2019
·
11 min read
Biotech Beach

Xencor to Present at Upcoming Investor Conferences - Nov. 13, 2019

Xencor, Inc. announced that company management will participate in two upcoming conferences

November 13, 2019
·
1 min read
BioForest

NanoString to Present at the Stifel 2019 Healthcare Conference

NanoString Technologies, Inc. announced that the company’s management is scheduled to present at the Stifel 2019 Healthcare Conference in New York City.

November 13, 2019
·
1 min read
Business

Personalis Reports Third Quarter 2019 Financial Results

Personalis, Inc., a leader in advanced genomics for cancer, reported financial results for the third quarter ended September 30, 2019.

November 13, 2019
·
8 min read
Genetown

Dicerna™ to Present at the Stifel 2019 Healthcare Conference

Dicerna™ Pharmaceuticals, Inc. announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019 at 11:30 a.m. EST in New York City.

November 13, 2019
·
2 min read
Deals

Phio Pharmaceuticals Announces Proposed Public Offering of Common Stock

Phio Pharmaceuticals Corp. announced that it has commenced a proposed public offering of shares of its common stock.

November 13, 2019
·
4 min read
Deals

CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock at $4.00 per share

CNS Pharmaceuticals, Inc. announced the closing of its initial public offering of 2,125,000 shares of common stock at an initial public offering price of $4.00 per share.

November 13, 2019
·
2 min read
Business

Dermira Elects Halley E. Gilbert to its Board of Directors

Dermira, Inc., a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, announced the election of Halley E. Gilbert to its board of directors.

November 13, 2019
·
5 min read
Business

Simulations Plus Reports FY2019 and Fourth Quarter FY2019 Financial Results

Simulations Plus, Inc. reported financial results for its 2019 fiscal year and fourth quarter ended August 31, 2019.

November 13, 2019
·
5 min read